{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:12:03Z","timestamp":1791216723343,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[1996,11]]},"abstract":"<jats:p><jats:italic>Background<\/jats:italic>The appetite suppressant aminorex fumarate is thought to have caused an epidemic of pulmonary hypertension in Europe in the 1960s. More recently, pulmonary hypertension has been described in some patients taking other amphetamine-like, anorexic agents: fenfluramine and its<jats:italic>d<\/jats:italic>-isomer, dexfenfluramine. No mechanism has been demonstrated that might account for the association between anorexic drugs and pulmonary hypertension.<\/jats:p><jats:p><jats:italic>Methods and Results<\/jats:italic>Using the whole-cell, patch-clamp technique, we found that aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in smooth muscle cells taken from the small resistance pulmonary arteries of the rat lung. Dexfenfluramine causes reversible membrane depolarization in these cells. These actions are similar to those of hypoxia, which initiates pulmonary vasoconstriction by inhibiting a potassium current in pulmonary vascular smooth muscle. In the isolated, perfused rat lung, aminorex, fenfluramine, and dexfenfluramine induce a dose-related increase in perfusion pressure. When the production of endogenous NO is inhibited by<jats:italic>N<\/jats:italic>-nitro-<jats:sc>l<\/jats:sc>-arginine methyl ester, the pressor response to dexfenfluramine is greatly enhanced.<\/jats:p><jats:p><jats:italic>Conclusions<\/jats:italic>These observations indicate that anorexic agents, like hypoxia, can inhibit potassium current, cause membrane depolarization, and stimulate pulmonary vasoconstriction. They suggest one mechanism that could be responsible for initiating pulmonary hypertension in susceptible individuals. It is possible that susceptibility is the result of the reduced production of an endogenous vasodilator, such as NO, but this remains speculative.<\/jats:p>","DOI":"10.1161\/01.cir.94.9.2216","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:34:42Z","timestamp":1339461282000},"page":"2216-2220","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":176,"title":["Anorexic Agents Aminorex, Fenfluramine, and Dexfenfluramine Inhibit Potassium Current in Rat Pulmonary Vascular Smooth Muscle and Cause Pulmonary Vasoconstriction"],"prefix":"10.1161","volume":"94","author":[{"given":"E. Kenneth","family":"Weir","sequence":"first","affiliation":[{"name":"the Department of Medicine, Veterans Affairs Medical Center and University of Minnesota, Minneapolis, Minn."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen L.","family":"Reeve","sequence":"additional","affiliation":[{"name":"the Department of Medicine, Veterans Affairs Medical Center and University of Minnesota, Minneapolis, Minn."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.C.","family":"Huang","sequence":"additional","affiliation":[{"name":"the Department of Medicine, Veterans Affairs Medical Center and University of Minnesota, Minneapolis, Minn."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Michelakis","sequence":"additional","affiliation":[{"name":"the Department of Medicine, Veterans Affairs Medical Center and University of Minnesota, Minneapolis, Minn."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Nelson","sequence":"additional","affiliation":[{"name":"the Department of Medicine, Veterans Affairs Medical Center and University of Minnesota, Minneapolis, Minn."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaclav","family":"Hampl","sequence":"additional","affiliation":[{"name":"the Department of Medicine, Veterans Affairs Medical Center and University of Minnesota, Minneapolis, Minn."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Archer","sequence":"additional","affiliation":[{"name":"the Department of Medicine, Veterans Affairs Medical Center and University of Minnesota, Minneapolis, Minn."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1111130"},{"key":"e_1_3_2_2_2","unstructured":"Mlczoch J. Drug and dietary induced pulmonary hypertension. In: Weir EK Reeves JT eds. Pulmonary Hypertension. New York NY: Futura; 1984:341-359."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.283.6296.881"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.292.6515.239-a"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.93.03050606"},{"key":"e_1_3_2_6_2","first-page":"776","volume":"67","year":"1991","unstructured":"Fotiadis I, Apostolou T, Koukoulas A, Michelacakis N, Kremastinos D. Fenfluramine-induced irreversible pulmonary hypertension. Postgrad Med J. 1991;67:776-777.","journal-title":"Postgrad Med J"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90129-Q"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90129-Q"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.70.6.537"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.74.6.660"},{"key":"e_1_3_2_11_2","first-page":"81","volume":"48","year":"1995","unstructured":"Cacoub P, Dorent R, Natlaf P, Houppe J, Piette J, Godeau P, Gandjbakhch I. Pulmonary hypertension and dexfenfluramine. Eur J Clin Pharmacol. 1995;48:81-83.","journal-title":"Eur J Clin Pharmacol"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03520140017007"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.9.2.7781921"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","unstructured":"Voelkel N Weir E. Etiologic mechanisms in primary pulmonary hypertension. In: Weir E Reeves J eds. Pulmonary Vascular Physiology and Pathophysiology. New York NY: Marcel Dekker; 1989:513-539.","DOI":"10.1201\/9781003573739-17"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1992.262.4.C882"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00656997"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0270(91)90017-T"},{"key":"e_1_3_2_18_2","first-page":"7583","volume":"9","year":"1994","unstructured":"Archer S, Huang J, Hampl V, Nelson D, Shultz P, Weir E. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci U\u2009S\u2009A. 1994;9:7583-7587.","journal-title":"Proc Natl Acad Sci U\u2009S\u2009A"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(91)90688-6"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91499-2"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)53573-0"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92983-9"},{"key":"e_1_3_2_23_2","first-page":"1","volume":"463","year":"1992","unstructured":"Barer G, Emery C, Stewart A, Bee D, Howard P. Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats. J Physiol. 1992;463:1-16.","journal-title":"J Physiol"},{"key":"e_1_3_2_24_2","first-page":"L587","volume":"264","year":"1993","unstructured":"Oka M, Hasunuma K, Webb S, Stelzner T, Rodman D, McMurtry I. EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs. Am J Physiol. 1993;264:L587-L597.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1994.76.2.933"},{"key":"e_1_3_2_26_2","first-page":"L667","volume":"267","year":"1994","unstructured":"Xue C, Rengasamy A, LeCras T, Koberna P, Dailey G, Johns R. Distribution of NOS in normoxic vs hypoxic rat lung: upregulation of NOS by chronic hypoxia. Am J Physiol. 1994;267:L667-L678.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/7.1.30"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.27.1.127"},{"key":"e_1_3_2_29_2","first-page":"110","volume":"11","year":"1970","unstructured":"Engelhardt A, Kroneberg G, Stoepel K, Stotzer H. The effects of acute and chronic administration of sympathomimetic substances on the systemic and pulmonary circulation. Proc Eur Soc Drug Toxicol. 1970;11:110-117.","journal-title":"Proc Eur Soc Drug Toxicol"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.26.3.262"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.27.1.120"},{"key":"e_1_3_2_32_2","first-page":"768","volume":"64","year":"1975","unstructured":"Stepanek J, Zak F. Zweijahrige perorale applikation von aminorex am hund 2. Teil. Z Kardiol. 1975;64:768-781.","journal-title":"Z Kardiol"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0143-4160(95)90076-4"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/8756-3282(94)00047-6"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01907748"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/151.3_Pt_1.692"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199243050-00007"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0022-3565(25)10599-5","volume":"274","year":"1995","unstructured":"Premkumar L, Ahern G. Blockade of a resting potassium channel and modulation of synaptic transmission by ecstasy in the hippocampus. J Pharmacol Exp Ther. 1995;274:718-722.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.104.2.614"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.94.9.2216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T19:47:12Z","timestamp":1743364032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.94.9.2216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,11]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1996,11]]}},"alternative-id":["10.1161\/01.CIR.94.9.2216"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.94.9.2216","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,11]]},"assertion":[{"value":"1996-01-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1996-06-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1996-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}